142 related articles for article (PubMed ID: 31629724)
1. Ten-year survival outcomes for patients with early stage classical Hodgkin lymphoma: An analysis from Kentucky Cancer Registry.
Myint ZW; Shrestha R; Siddiqui S; Slone S; Huang B; Ramlal R; Monohan GP; Hildebrandt GC; Saeed H
Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):17-22. PubMed ID: 31629724
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
3. Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.
Jhawar SR; Rivera-Núñez Z; Drachtman R; Cole PD; Hoppe BS; Parikh RR
JAMA Oncol; 2019 May; 5(5):689-695. PubMed ID: 30605220
[TBL] [Abstract][Full Text] [Related]
4. Patterns of care and outcomes of early stage I-II Hodgkin lymphoma treated with or without radiation therapy.
Weil CR; Parsons MJ; Hutten RJ; Lew FH; Johnson SB; Gaffney DK; Tao R
Leuk Lymphoma; 2022 Dec; 63(12):2847-2857. PubMed ID: 35904407
[TBL] [Abstract][Full Text] [Related]
5. Comparison of favorable early-stage hodgkin's lymphoma treatments: a single-institution review.
Samant R; Alomary I; Alsaeed E; Al-Jasir B; Bence-Bruckler I; Cross P; Genest P; Huebsch L
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1166-70. PubMed ID: 19695788
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.
Gunther JR; Fanale MA; Reddy JP; Akhtari M; Smith GL; Pinnix CC; Milgrom SA; Yehia ZA; Allen PK; Osborne EM; Mawlawi O; Dabaja BS
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):110-8. PubMed ID: 27325479
[TBL] [Abstract][Full Text] [Related]
7. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: a retrospective study.
Yang M; Ping L; Liu W; Xie Y; Aliya ; Liu Y; Nuersulitan R; Zhu J; Wu M; Song Y
Hematology; 2019 Dec; 24(1):413-419. PubMed ID: 30922173
[TBL] [Abstract][Full Text] [Related]
9. Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
Torok JA; Wu Y; Prosnitz LR; Kim GJ; Beaven AW; Diehl LF; Kelsey CR
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):54-9. PubMed ID: 25863754
[TBL] [Abstract][Full Text] [Related]
10. Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016.
Dores GM; Curtis RE; Dalal NH; Linet MS; Morton LM
J Clin Oncol; 2020 Dec; 38(35):4149-4162. PubMed ID: 32946352
[TBL] [Abstract][Full Text] [Related]
11. Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Eroglu C; Kaynar L; Orhan O; Keklik M; Sahin C; Yildiz OG; Mentes S; Kurnaz F; Aslan D; Sivgin S; Soyuer S; Eser B; Cetin M; Unal A
Am J Clin Oncol; 2015 Feb; 38(1):68-73. PubMed ID: 23563207
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma.
Bates JE; Parikh RR; Mendenhall NP; Morris CG; Hoppe RT; Constine LS; Hoppe BS
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):522-529. PubMed ID: 32173399
[TBL] [Abstract][Full Text] [Related]
13. Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India.
Bhurani D; Nair R; Rajappa S; Rao SA; Sridharan N; Boya RR; Raman GS; Menon H; Seshachalam A; Nimmagadda R
Front Oncol; 2021; 11():799948. PubMed ID: 35223455
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy or Combined Modality Therapy for Early-stage Hodgkin Lymphoma.
Torok JA; Wu Y; Chino J; Prosnitz LR; Beaven AW; Kim GJ; Kelsey CR
Anticancer Res; 2018 May; 38(5):2875-2881. PubMed ID: 29715111
[TBL] [Abstract][Full Text] [Related]
15. Favorable early-stage Hodgkin lymphoma.
Yahalom J
J Natl Compr Canc Netw; 2006 Mar; 4(3):233-40. PubMed ID: 16507270
[TBL] [Abstract][Full Text] [Related]
16. A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome.
Chohan KL; Young JR; Lester S; Alhaj Moustafa M; Rosenthal A; Tun HW; Hoppe BS; Johnston PB; Micallef IN; Habermann TM; Ansell SM
Blood Adv; 2022 Jul; 6(14):4241-4250. PubMed ID: 35617689
[TBL] [Abstract][Full Text] [Related]
17. Unfavorable early-stage Hodgkin lymphoma: assessment of patient characteristics in a real-world setting.
Gautam S; Yeola S; Nahar A; Sarpong EM; Prescott J; Yang X; Sineshaw HM
Future Oncol; 2023 Jun; 19(18):1249-1259. PubMed ID: 37293737
[TBL] [Abstract][Full Text] [Related]
18. Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.
Gandikota N; Hartridge-Lambert S; Migliacci JC; Yahalom J; Portlock CS; Schöder H
Cancer; 2015 Jun; 121(12):1985-92. PubMed ID: 25739719
[TBL] [Abstract][Full Text] [Related]
19. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
20. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
